1. Identification of phosphorylation sites in the COOH-terminal tail of the μ-opioid receptor. Chen YJ, Oldfield S, Butcher AJ, Tobin AB, Saxena K, Gurevich VV, Benovic JL, Henderson G, Kelly E (2013) J Neurochem 124(2): 189-99
    › Primary publication · 23106126 (PubMed) · PMC4226418 (PubMed Central)
  2. Engineering visual arrestin-1 with special functional characteristics. Vishnivetskiy SA, Chen Q, Palazzo MC, Brooks EK, Altenbach C, Iverson TM, Hubbell WL, Gurevich VV (2013) J Biol Chem 288(5): 3394-405
    › Primary publication · 23250748 (PubMed) · PMC3561558 (PubMed Central)
  3. Critical role of the central 139-loop in stability and binding selectivity of arrestin-1. Vishnivetskiy SA, Baameur F, Findley KR, Gurevich VV (2013) J Biol Chem 288(17): 11741-50
    › Primary publication · 23476014 (PubMed) · PMC3636863 (PubMed Central)
  4. Constitutively active rhodopsin mutants causing night blindness are effectively phosphorylated by GRKs but differ in arrestin-1 binding. Vishnivetskiy SA, Ostermaier MK, Singhal A, Panneels V, Homan KT, Glukhova A, Sligar SG, Tesmer JJ, Schertler GF, Standfuss J, Gurevich VV (2013) Cell Signal 25(11): 2155-62
    › Primary publication · 23872075 (PubMed) · PMC3774132 (PubMed Central)
  5. Arrestin-3 binds c-Jun N-terminal kinase 1 (JNK1) and JNK2 and facilitates the activation of these ubiquitous JNK isoforms in cells via scaffolding. Kook S, Zhan X, Kaoud TS, Dalby KN, Gurevich VV, Gurevich EV (2013) J Biol Chem 288(52): 37332-42
    › Primary publication · 24257757 (PubMed) · PMC3873585 (PubMed Central)
  6. The origin and evolution of G protein-coupled receptor kinases. Mushegian A, Gurevich VV, Gurevich EV (2012) PLoS One 7(3): e33806
    › Primary publication · 22442725 (PubMed) · PMC3307776 (PubMed Central)
  7. Synthetic biology with surgical precision: targeted reengineering of signaling proteins. Gurevich VV, Gurevich EV (2012) Cell Signal 24(10): 1899-908
    › Primary publication · 22664341 (PubMed) · PMC3404258 (PubMed Central)
  8. ßarrestin1-biased agonism at human δ-opioid receptor by peptidic and alkaloid ligands. Aguila B, Coulbault L, Davis A, Marie N, Hasbi A, Le bras F, Tóth G, Borsodi A, Gurevich VV, Jauzac P, Allouche S (2012) Cell Signal 24(3): 699-707
    › Primary publication · 22101011 (PubMed) · PMC3392209 (PubMed Central)
  9. Silent scaffolds: inhibition OF c-Jun N-terminal kinase 3 activity in cell by dominant-negative arrestin-3 mutant. Breitman M, Kook S, Gimenez LE, Lizama BN, Palazzo MC, Gurevich EV, Gurevich VV (2012) J Biol Chem 287(23): 19653-64
    › Primary publication · 22523077 (PubMed) · PMC3366000 (PubMed Central)
  10. Role of receptor-attached phosphates in binding of visual and non-visual arrestins to G protein-coupled receptors. Gimenez LE, Kook S, Vishnivetskiy SA, Ahmed MR, Gurevich EV, Gurevich VV (2012) J Biol Chem 287(12): 9028-40
    › Primary publication · 22275358 (PubMed) · PMC3308753 (PubMed Central)